A Global Shift in Access to Emergency Contraception
When Japan approved over-the-counter (OTC) emergency contraceptives for the first time, it marked more than just a policy change—it signaled a global moment. While some countries continue expanding reproductive autonomy, others, like the United States, have taken steps backward.
This shift inspired me to look deeper: What is the current landscape of emergency contraception (EC), and how can sexual health professionals ensure that access and understanding continue to grow rather than retreat?
Emergency contraceptive pills (ECPs) are one of the most effective tools we have to prevent unintended pregnancy and unsafe abortion, yet they remain underused and often misunderstood. Let’s explore what EC is, why it matters, how it’s being used globally, and what professionals can do to make it part of everyday sexual health conversations.
What Is Emergency Contraception? A Quick Refresher
Emergency contraception prevents pregnancy after unprotected vaginal sex or contraceptive failure. When used correctly, EC can prevent over 95% of pregnancies, working up to five days after intercourse.
Here’s how it works: EC delays or inhibits ovulation. It does not affect implantation or harm an existing pregnancy.
Copper IUD: Effective up to 5 days post-intercourse; can double as ongoing contraception.
Emergency Contraceptive Pills (ECPs):
Ulipristal acetate (UPA) – 30 mg single dose
Levonorgestrel (LNG) – 1.5 mg single or split dose
Yuzpe regimen – combined estrogen/progestin
Side effects are usually mild (e.g., nausea, fatigue, or menstrual changes) and self-limited. The key message for clients: EC is safe, effective, and should be used as soon as possible.
A Brief History of Emergency Contraception: From the Yuzpe Era to Ulipristal
The story of emergency contraception began in the 1960s with the Yuzpe method, a combination of estrogen and progestin. Over the decades, research led to more effective and accessible methods—first levonorgestrel-only pills, then ulipristal acetate, and the copper IUD as a postcoital option.
Each advancement reflected a deeper truth: when people are given timely, stigma-free access, they are better able to make decisions about their bodies and futures.
Why Access to EC Matters
Unsafe abortions remain a leading cause of preventable maternal deaths, particularly in lower-income regions where 30 to 520 women die per 100,000 unsafe abortions. EC fills a critical gap in reproductive health, especially in places where contraceptive options are limited or abortion access is restricted.
Expanding EC isn’t just a policy matter; it’s a public health imperative and a human rights issue.
Global Landscape: Progress and Persistent Gaps
The world is making strides—but progress is uneven.
Over 90 countries allow EC without a prescription.
36 countries still require one.
21 countries have unclear or unregistered access.
Knowledge gaps persist even where EC is available. Awareness, cost, and stigma all shape whether individuals can actually use EC when they need it.
In Japan, for example, contraception was not covered by national health insurance, and the cost of EC ranged from ¥6,000–20,000 (USD $55–190) with only 3% of hospitals and clinics providing EC consultations. Japan’s move toward OTC access marks an important cultural and systemic milestone that could have big implications for accessibility and affordability.
Across regions, similar efforts are underway; from Asia-Pacific advocacy networks pushing for pharmacy-based access, to European countries integrating EC into routine sexual health counseling, to U.S. states navigating a deeply divided policy landscape.
The U.S. Rundown: Access, Attitudes, and Inequities of Emergency Contraception
In the United States, EC access has expanded legally but remains uneven in practice.
In 2006, EC became available without a prescription for those 17 and older.
By 2014, age restrictions were lifted entirely.
Yet, state-level policies now vary widely—32 states have specific protections or restrictions for EC.
Use has increased over time:
In 2006–2008, about 18% of adolescent girls and young women reported using EC.
By 2015–2017, that number rose to 32%, with access through pharmacies jumping from 31% to 70%.
Still, insurance coverage is inconsistent. The average cost of an EC pill is $40–50, and many must pay out-of-pocket.
The Dobbs decision (which overturned Roe v. Wade) temporarily drove up EC sales, but within a year, sales fell 65% in restrictive states, highlighting how policy and stigma continue to shape access.
Attitudes and Stigma: What Patients Are Telling Us
Studies of young adults ages 19–26 show positive attitudes toward EC, viewing it as empowering and essential to autonomy. Yet stigma persists, which is rooted in misinformation, moral judgment, and provider discomfort.
This is where professionals can make a difference. Normalizing EC as part of routine contraceptive care can reduce shame, improve access, and promote informed decision-making.
Counseling Strategies for Providers
Effective EC counseling requires both relational and task-oriented communication.
Relational communication:
Reduce shame by affirming autonomy and using destigmatizing language.
Task-oriented communication:
Offer clear, factual information on timing, side effects, and follow-up options.
Use “if-then” strategies to help clients plan ahead (e.g “If my condom breaks, I’ll go to the pharmacy for EC within 24 hours.”)
Be proactive: bring up EC during general contraceptive discussions, not just in emergencies.
Encourage transitions to ongoing methods if desired.
Research even shows that “if-then” planning can reduce missed opportunities for EC use and follow-up consultations.
Despite the evidence, EC counseling among U.S. adolescents and young adults remains shockingly low: around 5%. This is an urgent area for practice improvement.
Moving Forward: Where Practice Meets Advocacy
The next phase of EC advancement isn’t just about availability, it’s about acceptance, education, and integration.
We need:
More research on cultural, social, and religious influences on EC use.
Public education campaigns that reduce stigma and misinformation.
Integration of EC into pharmacy practice, sexual health curricula, and primary care protocols.
Continued advocacy to ensure affordability and equity, especially for historically excluded communities.
Takeaways on Emergency Contraception
Emergency contraception is safe and effective, but still underused. This is not because of biology, but because of barriers in knowledge, stigma, and policy.
Sexual health professionals play a pivotal role in reframing EC from an “emergency fix” to a core component of reproductive health and justice. Expanding access and normalizing EC conversations are key steps toward empowering patients and advancing equity.
Want to continue your journey as a sexual health professional and help others navigate conversations around sexuality, contraception, and reproductive health?
Resources for Professionals
World Health Organization: Emergency Contraception Fact Sheet
Contraceptive Security Indicators Survey (EC Trends)
Guttmacher Institute: State-level EC policy tracker
Regional databases: Asia-Pacific, Europe, and Sub-Saharan Africa
Written by Emma Sell-Goodhand, MPH
Emma is a doctoral student and Global One Health Fellow at North Carolina State University studying adolescent sexual health. She brings prior experience as a Technical Advisor at the World Health Organization.
Want to become an in-demand sexual health professional? Learn more about becoming certified with SHA!
